NeoGenomics, Inc.
NEO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $197,504 | $187,061 | $241,760 | $417,465 |
| - Cash | $164,117 | $154,723 | $346,194 | $367,012 |
| + Debt | $410,308 | $411,763 | $604,781 | $605,334 |
| Enterprise Value | $443,695 | $444,101 | $500,347 | $655,787 |
| Revenue | $187,797 | $181,330 | $168,035 | $172,000 |
| % Growth | 3.6% | 7.9% | -2.3% | – |
| Gross Profit | $80,446 | $77,258 | $73,246 | $77,257 |
| % Margin | 42.8% | 42.6% | 43.6% | 44.9% |
| EBITDA | -$9,952 | -$27,619 | -$6,311 | $3,684 |
| % Margin | -5.3% | -15.2% | -3.8% | 2.1% |
| Net Income | -$27,129 | -$45,092 | -$25,923 | -$15,324 |
| % Margin | -14.4% | -24.9% | -15.4% | -8.9% |
| EPS Diluted | -1.05 | -1.75 | -1 | -0.6 |
| % Growth | 40% | -75% | -66.7% | – |
| Operating Cash Flow | $8,884 | $20,330 | -$25,327 | $9,800 |
| Capital Expenditures | -$8,314 | -$6,323 | -$4,500 | -$11,599 |
| Free Cash Flow | $570 | $14,007 | -$29,827 | -$1,799 |